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Abstract
Background: Obesity is a risk factor for knee arthritis. Total knee arthroplasty is the definitive
surgical treatment of this disease. Therefore, a high percentage of subjects treated are overweight.
Since 2000 in the Emilia-Romagna Region the Register of Orthopedic Prosthetic Implantology,
RIPO, has recorded data of all the primary and revision operations performed on the knee; height
and weight of patients at the time of surgery have also been recorded.
Methods: To understand how overweight and obesity affect the outcome of knee arthroplasty, a
population of subjects treated with cemented total knee arthroplasty between 2000 and 2005 was
studied. 9735 knee prostheses were implanted in 8892 patients; 18.9% of the patients were normal
weight, 48.2% were overweight (25 < Body Mass Index <= 30), 31.1% were obese (30 < BMI <=
40), and 1.8% were morbidly obese (BMI > 40). Mean and range of follow-up were respectively 3.1
and 1.5–6 yrs. Implant failure was defined as the exchange of at least one component for whatever
reason.
Results: In normal weight patients there were 36 failures out of 1840 implants (1.96%), in
overweight patients there were 87 out of 4692 (1.85%), in obese 59 out of 3031 (1.94%), and in
morbidly obese there were 4 out of 172 (2.3%). The mean time to failure for each class was 1.57,
1.48, 1.60, 1.77 yrs. Cox regression analyses showed that the risk of implant failure was not
influenced by BMI, absolute body weight, or sex. Conversely, an increased failure risk was observed
in mobile meniscus prostheses in comparison with those with a fixed meniscus (Rate Ratio 1.88);
an increased failure risk was also related to age (Rate Ratio 1.05 per year). These results were also
confirmed when considering septic loosening as the end-point. There were no differences in the
rate of perioperative complications and death in the 4 classes of BMI.
Conclusion: In conclusion, cemented knee prostheses, implanted in patients with arthritis do not
have significantly different rates of survival or perioperative complications in obese subjects
compared with normal weight subjects, at least up to 5 years after surgery. The conclusion also
applies to subjects affected by morbid obesity, altough this findings should be regarded with caution
due to the small sample examined.
Published: 5 March 2009
BMC Musculoskeletal Disorders 2009, 10:29 doi:10.1186/1471-2474-10-29
Received: 27 March 2008
Accepted: 5 March 2009
This article is available from: http://www.biomedcentral.com/1471-2474/10/29
© 2009 Bordini et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 8
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2009, 10:29 http://www.biomedcentral.com/1471-2474/10/29Background
The prevalence of obesity in industrialized and emerging
countries is reaching epidemic proportions. The growth of
the population with an unhealthily high body weight is
particularly relevant in the USA where 71% of the inhab-
itants over 60 years old are overweight or obese [1],
although it has reached warning levels in many European
countries [2-6] and Australia [7].
In Italy obesity is a public health problem: 39% of women
and 50% of men over 65 of age are overweight and 15%
and 14% respectively are obese. In the Emilia Romagna
Region, in the North of the Country where most of the
population considered in this study live, in the same age
range, 42% of women and 55% of men are overweight
and 13% and 14% are obese [8].
Obesity is related to several cardiovascular, metabolic,
and osteoarticular diseases, especially arthritis of the knee
and hip, and also other joints bearing smaller loads, thus
suggesting both a mechanical and biochemical role in
articular degeneration [9,10]. Treatment of arthritis is ini-
tially conservative using drugs and physiotherapy, but
often, as the disease progresses, total joint arthroplasty
becomes necessary. Therefore, many obese subjects can be
found among those treated by total joint arthroplasty and
the correlation between BMI (Body Mass Index) and oste-
oarthritis is now clear. Oliveria demonstrated that the risk
of symptomatic osteoarthritis of the knee increased dra-
matically with increasing BMI (3.8 for BMI up to 30 and
9.3 for BMI > 30) [11]. Similarly, each unit in age-adjusted
BMI has been shown to be associated with a 4% increase
in incidence of osteoarthritis [12].
Based on these premises, the practice of knee joint arthro-
plasty is becoming more widespread worldwide [13-17]
and its efficacy is undisputed [18].
Besides clinical experience, all implant Registers starting
from 1975, following the example of Sweden, have con-
firmed the excellent results of this surgical procedure. In
Italy RIPO (Register of the Orthopedic Prosthetic Implan-
tology) began in 2000 in Emilia Romagna, a region count-
ing 4.500.000 inhabitants; it captures 95% of the
operations either primary and revision performed in the
61 public and private health structures of the Region [19].
Revisions undertaken in other regions of Italy are
included, because the economic compensation among
administrative services of Italian regions allows RIPO not
to lose these patients to follow-up. Even if good results are
generally obtained with total knee arthoplasy (TKA),
some authors have raised doubts about its effectiveness in
obese subjects, so much so that recently the East Suffolk
Health trust prioritized non-obese (BMI < 30) in the selec-
tion of patients for lower limb joint replacement surgery
[20].
The scientific community does not fully agree with this
choice since there is no clear and definitive evidence of the
effectiveness of the operation in obese patients. The liter-
ature, in fact, mainly shows the data of limited series,
which do not provide a unanimity of views, both with
regards to the different endpoints used in the definition of
success, and the different stratifications performed in the
patients.
The purpose of the present study was therefore to try to fill
this gap and examine the relationship between body mass
index and survivorship of knee prostheses on a register-
based data-set.
Methods
The data collected by RIPO in the period 2000–2005 were
analyzed so as to have at least an 18-month follow-up.
The study was performed on patients treated by fully
cemented total knee prosthesis due to primary arthritis.
This method of prosthesis fixation was used in 88% of the
implants recorded in RIPO. A total of 11,529 knees were
eligible for the study. Of these knees 1,794 (15.6%) were
excluded due to missing information about weight or
height, thus leaving 9,735 knees in 8,892 patients for eval-
uation. The outcomes of interest were compared between
obese and non-obese patients. We used BMI to define
obesity; according to the guidelines set by the World
Health Organization BMI > 25 and < 30 Kg/m2 was
defined as overweight, BMI >= 30 kg/m2 as obese, and
BMI >= 40 as morbidly obese.
The distribution of the variables considered in the subse-
quent analyses (gender, age, type of insert) is shown in
Table 1. They are not statistically different comparing the
cases excluded with those included in the study. In the
group of included patients, 567 died in the follow up
period, 118 of them were normal weight, 275 overweight,
163 obese and 11 morbidly obese. The incidence is
respectively 6.4%, 5.8%, 5.4%, 6.4%, not significantly dif-
ferent (Fisher exact test). In all cases the prosthesis was
still in place at the time of death.
The most commonly used totally cemented knee prosthe-
ses in this study are presented in Table 2. They are grouped
according to the type of insert, as this variable, in RIPO
data, has been shown to influence the survival of the pros-
thesis [21].
The primary outcome in the analysis was revision of at
least one component. The analysis was repeated using
three different endpoints: revision of at least one compo-
nent for whatever reason; revision of at least one compo-Page 2 of 8
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reason. The insertion of a patellar button in a second stage
was not considered as failure of the prosthesis according
to the policy of the Register
The secondary outcome was the incidence of main com-
plications during hospitalization. Complications were
recorded by the surgeon at time of discharge from the hos-
pital and transmitted to the register together with all the
other information about the patient and prosthesis.
Statistics
Cox proportional hazards regression was applied to esti-
mate the effects of the different covariates on the failure
rate. The hazard ratios are presented with ninety five per-
cent confidence intervals. The end-point was revision of at
least one component. Variables included gender, age, type
of insert and BMI or weight. The Cox multiple regression
model test enables verification of the influence of one var-
iable on equal terms with the others [22].
Results
The first primary end-point tested was the revision of at
least one component for whatever reason. The result of
multiple regression model is summarized in Table 3.
In the analysis the total number of valid observations was
9,735 of which 9,549 were not removed and 186 were
revised.
The outcome was not statistically significant affected by
gender or by BMI class, but was affected by age and type
of insert.
Then the analysis was repeated using the second primary
end-point, which was septic loosening. In the analysis the
total number of valid observations was 9735 of which
9677 were not removed and 58 were revised due to infec-
tion (Table 4).
Table 1: Characteristics of the examined population.
EXAMINED Men Women Total number (%)
Number of patients 2102 6790 8892
N. of prostheses 2281 7454 9735
Mean age at surgery
(C.I 95%)
71.4
(71.1–71.7)
72.1
(71.9–72.2)
71.9
(71.8–72.1)
BMI
Normal (BMI <= 25) 426 1414 1840 (18.9%)
Overweight (25 < BMI <= 30) 1252 3440 4692 (48.2%)
Obese (30 < BMI <= 40) 580 2451 3031 (31.1%)
Morbidly obese (BMI > 40) 23 149 172 (1.8%)
Type of insert
Fixed 1612 5312 6924 (71.1%)
Mobile 669 2142 2811 (28.9%)
Table 2: Types of cemented total knee prostheses implanted in the patients. Number of implants and failures are reported for each of 
them
FIXED INSERT MOBILE INSERT
n Type n Type
1889/27 NEXGEN – LPS – Zimmer 484/15 PFC – RP – PS – De Puy Johnson & Johnson
1739/27 PROFIX – CONFORMING – Smith & Nephew 334/10 GENIUS TRICCC – Dedienne Sante
379/2 NEXGEN – LPS – FLEX FISSO – Zimmer 317/13 T.A.C.K. – Link
243/5 ADVANCE Medial Pivot – Wright 221/1 GEMINI MK II – Link
235/6 OPTETRAK – P.S. – Exactek 201/2 NEXGEN – LPS – FLEX MOBILE – Zimmer
215/2 913 – PS – Cremascoli Wright 175/8 ROTAGLIDE – Corin Medical
184/4 PFC – PS – De Puy Johnson & Johnson 154/7 LCS – UNIVERSAL – RP – De Puy J & J
171/11 INTERAX – Diamond Condilar – Stryker Howmedica 124/2 HLS – EVOLUTION ROTATOIRE – Tornier
154/1 SCORPIO – P.S. – Osteonics 801/19 Other (less than 100 each)
134/1 PROFIX – PLUS CONFORMING – Smith & Nephew
121/4 DURACON II – LIPPED – Stryker Howmedica
116/0 AGC V2 HPPS TOTAL KNEE – Biomet Merck
111/0 SCORPIO – NRG – PS – Osteonics
1233/19 Other (less than 100 each)Page 3 of 8
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repleacing some variable (weight instead of BMI, BMI as
continuous variable), and adding the variable 'surgeon's
experience' (surgeons having performed more than 180
knee arthroplasties in the period were considered
experts). The results were unchanged even if the endpoint
was limited to the exchange of the polyethylene insert
(data not shown).
Table 3: Results of multiple regression model of knee prosthesis revision (whatever reason)
Failures/Implants Unadjusted
(95% CI)
Adjusted for all variables*
(95% CI)
P
(adjusted model)
Gender p = 0.223
Female 135/7454 1 (referent) 1(referent)
Male 51/2281 1.29
(0.93–1.78)
1.22
(0.88–1.69)
Insert p = 0.0001
Fixed 109/6924 1 (referent) 1 (referent)
Mobile 77/2811 1.85
(1.38–2.48)
1.88
(1.40–2.52)
Age at surgery
(for year)
186/9735 0.95
(0.94–0.97)
0.95
(0.94–0.97)
p = 0.0001
Body Mass Index p = 0.965
Normal (BMI <= 25) 36/1840 1 (referent) 1 (referent)
Overweight (25 < BMI <= 30) 87/4692 0.97
(0.66–1.43)
0.92
(0.62–1.35)
p = 0.661
Obese (30 < BMI <= 40) 59/3031 1.04
(0.69–1.57)
0.91
(0.597–1.382)
p = 0.654
Morbidly obese (BMI > 40) 4/172 1.29
(0.46–3.6)
1.02
(0.36–2.90)
p = 0.967
* Gender, type of insert, age at surgery, body mass index
Table 4: Results of multiple regression model of knee prosthesis revision due to infection.
Failures/Implants Unadjusted
(95% CI)
Adjusted for all variables*
(95% CI)
P
(adjusted model)
Gender p = 0.228
Female 40/7454 1 (referent) 1(referent)
Male 18/2281 1.53
(0.87–2.66)
1.41
(0.81–2.48)
Insert p = 0.002
Fixed 31/6924 1 (referent) 1 (referent)
Mobile 27/2811 2.26
(1.35–3.78)
2.28
(1.36–3.82)
Age at surgery
(for year)
58/9735 0.95
(0.92–0.99)
0.95
0.92–0.99)
p = 0.008
Body mass index p = 0.851
Normal (BMI <= 25) 10/1840 1 (referent) 1 (referent)
Overweight (25 < BMI <= 30) 31/4692 1.24
(0.61–2.53)
1.17
(0.57–2.38)
p = 0.67
Obese (30 < BMI <= 40) 16/3031 1.01
(0.46–2.22)
0.89
(0.40–1.98)
p = 0.78
Morbid obese (BMI > 40) 1/172 1.15
(0.15–8.99)
0.94
(0.12–7.49)
p = 0.96
* Gender, type of insert, age at surgery, body mass indexPage 4 of 8
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plications during hospitalization are shown in Table 5.
The rate was not statistically significant different in the 4
classes of BMI. Hospitalization duration was not statisti-
cally significant different in the 4 classes, as well, ranging
between 11.7 and 12.5 days.
Discussion
There is great interest in excess bodyweight in TKA,
because obesity is closely related to knee arthritis and, as
a consequence, because a high percentage of patients
treated with TKA are overweight or obese.
The purpose of the present paper was to test, based on the
data collected by the RIPO, the influence of obesity on
outcomes of TKA. Only cemented prostheses implanted
in patients with arthritis were considered, in order to
reduce potential biases. Cementless or partially cemented
knee prostheses represent, in fact, only 12% of all regis-
tered implants, and pathologies other than arthrosis only
11%.
The primary end-point selected, as applies to the analyses
performed on the register data, was the removal of even
only one prosthetic component either for septic or aseptic
loosening.
The secondary end-point was the rate of complications
and deaths observed during hospitalization.
The results obtained show that BMI does not influence the
survival of the implant at a 5-year maximum follow-up
due to either aseptic or septic loosening. No influence was
observed for the rate of complications or deaths observed
during hospitalization; length of hospitalization was
comparable in the 4 classes.
BMI did not increase the risk of failure even in the few
cases where it was extremely high, in patients with morbid
obesity.
Furthermore, even absolute body weight does not appear
to be a risk factor for implant failure. Differentiation
between weight and obesity is important as one is an
absolute measure and the other a relative one. A patient
weighting 80 Kg is classified as normal if 180 cm high and
obese if 160 cm high. The stress on the prosthesis is
unmodified, but BMI class is different.
Conversely, multiple regression model has shown the
negative influence of the type of insert on the survival of
the prosthesis; the mobile bearing being worse than the
fixed one, both when the endpoint was failure for any rea-
Table 5: Rate of intraoperative, local postoperative, and general complications and deaths according to class of Body Mass Index (BMI) 
of the patients treated by total knee arthroplasty.
n. of trated patients Patients with 
intraoperative 
complications 
(% of the total)
Patients with postoperative 
complications 
(% of the total)
Patients with general 
postoperative 
complications
(% of the total)
Deaths in hospital
BMI <= 25 1840 9 (0.49)
5 bone fracture, 3 tendon 
rupture, 1 anest. complic
26 (1.4)
16 hematoma, 4 nerve 
injury
0 deep thrombosis
6 other
55 (3.0)
3 pulmonary embolism, 5 
minor cardiac
14 acute anemia
5 urinary
28 other
2 (0.1)
25 < BMI <= 30 4692 13 (0.27)
4 bone fracture, 6 tendon/
ligam rupture, 2 hemorrage
1 anest. complic
65 (1.4)
37 hematoma, 4 nerve 
injury
7 deep thrombosis
22 other
143 (3.0)
11 pulmonary embolism, 7 
cardiac infarction
4 minor cardiac
32 acute anemia
17 urinary
72 other
5 (0.1)
30 < BMI <= 40 3031 7 (0.23)
3 bone fracture, 2 tendon/
ligam rupture, 1 anest. 
complic
33 (1.1)
15 hematoma, 2 nerve 
injury
6 deep thrombosis
4 superficial infections
3 other
98 (3.2)
3 pulmonary embolism, 1 
cardiac infarction
7 minor cardiac
17 acute anemia
15 urinary
55 other
1 (0.03)
BMI > 40 172 0 - 3 (1.7)
2 hematoma, 1 other
6 (3.5)
1 cardiac infarction
5 other
1 (0.58)
Total 9735 29 (0.30) 127 (1.3) 302 (3.1) 9 (0.1)
Rate of complications and deaths is not significantly different in the 4 classes of BMI. Fisher's exact Test > 0.05.Page 5 of 8
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include the type of mobility of the insert in the analysis
was prompted by evidence already observed both in the
RIPO data and in the data of the Australian register that
shows how the mobile insert is worse than the fixed one
[17]. Indeed we confirmed that the rate-ratio (RR) was
1.88 when the end point was loosening for any reason,
which increased to 2.28 when the end-point was septic
loosening. The interpretation of this finding is not simple.
The reason may be the smaller size of the polyethylene
particles that are generated by mobile-bearing knees
owing to the more conformed articular surface and addi-
tional undersurface wear. [23],
The same analysis showed that the survival of the prosthe-
sis was positively influenced by the increase in the
patient's age at surgery. In fact, an increase by only one
year of age reduces the risk of loosening, possibly due to
the reduction in the patient's motor activity. [14]
A possible bias in these results might derive from the
observation that obese patients are less likely to be offered
a revision. On the contrary we verified that surgeons, in
the region where the study was conducted, do not refuse
revision surgery even to obese patients. Only very severe
co-morbidities, and not obesity itself, can prompt anes-
thetists to contraindicate anesthesia.
A comparison with the data of the literature can be made
only with series collected in single centres. Large series of
registers in fact are lacking, because BMI is not recorded by
the registers that historically deal with the knee [14-17], or
it is recorded but has not yet been elaborated, as in Eng-
land, where the follow-up is too short.
On the whole, the panorama of experiences on this matter
is variegated because the end-points, the classification of
obesity, and the follow-ups are different and probably
because the series rarely exceed a hundred patients. [24]
Taking the revision of the prosthesis as the end-point, our
results agree with authors that have published mid-term
studies, such as Amin, who compared 125 obese with 158
non-obese patients and concluded that simple obesity
(BMI > 30 but < 40) did not influence the clinical out-
come or revision rate 5 years after TKA [25], and Spicer,
who studied 285 osteoarthritic obese patients at a mean
follow-up of 6 years and observed that survivorship of the
prostheses was similar to that of non-obese patients [26].
Foran [27] studied 68 obese and 68 non-obese patients,
Kaplan Meier survivorship analysis revealed that obese
and non-obese patients behave in a similar way up to 60–
80 months from surgery (albeit with a better quality of life
in non obese patients), and then a decrease in survival rate
becomes apparent for the obese group.
Our results also agree with longer-term follow-up studies,
up to ten years, where obese and non-obese patients have
a similar pattern [28,29] and where TKA resulted in
improved mobility, thus enhancing the chance of success
of subsequent weight loss therapy [30].
Again with a long-term follow-up, other authors have
found results that differ from ours despite using the same
statistical method. Among them Foran who followed a
smaller cohort of 27 non-obese and 27 obese patients
with a cementless prosthesis for 15 years and found a
trend not statistically significant for obesity to influence
the rate of aseptic loosening, but a higher revision rate of
poly liners in non-obese patients, probably due to a
higher rate of activity [31]. Vazquez-Vela Johnson, fol-
lowed 145 patients for more than 10 years and observed
that age, gender and BMI all make a difference to the sur-
vival rate of osteoarthritic patients; male gender, obesity
and age below 60 years are risk factors for prosthesis sur-
vival [32].
Concerning complications, Miric, found that heavier
patients were more likely to experience a complication
(38% versus 25%) and multiple complications (9.3% ver-
sus 6.2%) compared with lighter patients [33].
A longer follow-up might reveal phenomena that cannot
be seen yet, despite the large size of the sample we have
studied.
Another question is patients with morbid obesity (BMI >
40). Different conclusions have been reached also with
regards to these patients, based on extremely small series.
Krushell 2007 found that 39 patients with a BMI > 40 had
higher rate of revision but did not reach statistical signifi-
cance [34].
Conversely, Amin compared 41 obese with 41 morbidly
obese patients for a mean of 38 months after knee replace-
ment and found that the second group suffered a higher
rate of complications and peri-implant radiolucency [35].
Winiarsky studied 40 morbidly obese patients with a min-
imum follow-up of 2 years and found more perioperative
complications in these patients. [36]
Altogether the three Authors studied 120 patients, a very
low number, as is the series reported in our study, which
includes 172 morbidly obese patients. The shortage of
patients in this group is related not only to the extreme
condition they were in, but also the difficulty to find both
orthopedic surgeons and anesthetists willing to treat these
"risk" subjects.Page 6 of 8
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sis, except for Winiarsky [36]. The data we have presented
are certainly limited by the chosen end-point that is surgi-
cal revision of at least one component. Nothing is known
about the quality of life and radiological aspects of the
patients, another limit of the study is the short follow-up.
In fact the minimum follow-up of 18 months and maxi-
mum of 60 does not reveal the late phenomena of poly-
ethylene wear, which, however, at least in this short
follow-up, does not seem to penalize obese patients.
Undoubtedly, the time of observation is limited in com-
parison with the life expectancy of the prosthesis; there-
fore it is not possible to extend the conclusions to the real
duration of the prosthesis itself.
Further limits of the study are the lack of knowledge of the
level of physical activity of the patients and all the other
elements of clinical follow-up, such as degree of pain
relief, weight change, smoking habits, besides the possible
use of surgical navigator. Obese patients might practise a
lower level of activity in comparison with normal weight
patients which limits the wear of the polyethylene, thus
compensating for the greater stress due to body weight,
and patients that were obese during the operation might
have lost some body weight thanks to the restoration of
function of the replaced joint.
In our opinion, these limits are balanced by the great
strength of a multicentric series of over 9700 arthroplast-
ies performed with prostheses of different types, all totally
cemented to treat a homogeneous series of osteoarthritic
patients. Furthermore, our large series has allowed us to
analyze the data with a multivariate statistical method,
thereby testing the weight of the risk factors.
Conclusion
The link between excessive body weight and health is an
important concern for public health policy, because obes-
ity is a well-known risk factor for many costly diseases
such as cardiovascular disease, diabetes and some types of
cancer.
Based on our evidence, however, it does not appear justi-
fied to give low priority to obese sujects for TKA which
would, in virtue of restored ability to move, lead to weight
loss, which undoubtedly, should be the primary objective.
In conclusion, according to the Register data and consid-
ering the limits that this type of data can have, at present
it can be said that up to 5 years after surgery obese subjects
do not run a higher risk of totally cemented knee prosthe-
sis revision. These patients do not carry a greater risk of
perioperative complications either. The conclusion also
applies to subjects affected by morbid obesity, albeit with
caution related to the small sample examined.
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